San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

FDA Approves Immunodeficiency Treatment From Halozyme Therapeutics And Baxter

San Diego-based Halozyme Therapeutics and Baxter International Inc. announced that the United States Food and Drug Administration approved Baxter’s subcutaneous treatment, HYQVIA, for adult patients with primary immunodeficiency.

Tease photo

ResMed Integrates Its Sleep Apnea Monitoring With Network's Electronic Medical Records

ResMed, a San Diego-based company that develops medical devices for sleep apnea and other sleep-related breathing disorders, announced that its AirView compliance management is now connected to Fairview Health Services' Epic EHR system, enabling up to date delivery of sleep apnea patient data for use by the medical staff of Fairview, a network of hospitals and clinics throughout Minnesota.

FDA Approves Orexigen's Weight-Loss Drug

The U.S. Food and Drug Administration announced that it approved a weight-loss drug developed by La Jolla-based Orexigen Therapeutics Inc.

MabVax Therapeutics Announces Agreements on Product Development

MabVax Therapeutics Holdings Inc., a clinical stage oncology drug development company, announced that it has entered into agreements with Memorial Sloan Kettering Cancer Center and Juno Therapeutics for the development of therapeutic products using antibody targeting sequences derived from the fully-human antibodies discovered using the MabVax antibody discovery platform.

J. Craig Venter Institute Names Chief Operating Officer

The J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, announced today that they have hired Nicole DeBerg as chief operating officer.

Tease photo

Aethlon and Subsidiary Announce Development of Cancer Diagnostic

San Diego-based Aethlon Medical Inc. and its diagnostic subsidiary, Exosome Sciences Inc. announced that their researchers have developed and initially validated a diagnostic platform that could identify the presence of cancer in analyzed blood samples.

Tease photo

Astute Medical Inc. Receives FDA Clearance for Biomarker-Based Immunoassay

San Diego-based Astute Medical Inc. today announced that it has received clearance from the Food and Drug Administration to commence sales of its first biomarker-based immunoassay, NephroCheck.

Tease photo

ResMed, APEX Settle Patent Disputes

San Diego--based ResMed Inc. and APEX Medical Corp. have agreed to a confidential settlement resolving their outstanding patent disputes.

Tease photo

Company Develops Prototype for Treatment of Rare Skin Diseases

Biotech: The Device Is a Less Expensive Solution For Incurable Skin Disorders

Martyn Gross has suffered from psoriasis for most of his life, particularly on the difficult-to-treat regions of the hand and feet. After years of trying costly and ineffective treatments from uncomfortable phototherapy sessions in cold medical facilities to topical creams that wash off too easily, Gross decided to develop a handheld light therapy device to treat himself at home.

Tease photo

Targeted Medicine Changes Clinical Trials

HEALTH: Sequencing and Analytics Part of Process

Recent trends in biotech research point to faster, more efficient and less costly drug development for pharmaceutical companies.

Ajinomoto Althea Receives OK for Testing Drugs for European Market

San Diego-based Ajinomoto Althea Inc., a biopharmaceutical contract development and manufacturing company, has received clearance to test its commercial drug products for the European market.

Tease photo

Mirati Begins Phase One of Trials for Tumor Treatment

Mirati Therapeutics Inc. announced that the first patient has been dosed in its phase one clinical study for the treatment of patients with advanced solid tumors.

Tease photo

Halozyme Drug Candidate Granted Fast Track Status

Halozyme Therapeutics Inc. announced that the Food and Drug Administration has granted Fast Track designation for its program investigating a treatment for patients with metastatic pancreatic cancer.

Tease photo

RuiYi Inc. Names Saad to CFO Position

RuiYi Inc. announced today the appointment of Mark Saad as chief financial officer.